These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 12397691)
21. Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial. Peters S; Götting B; Trümmel M; Rust H; Brattström A J Invasive Cardiol; 2001 Feb; 13(2):93-7. PubMed ID: 11176015 [TBL] [Abstract][Full Text] [Related]
22. Combined treatment with statin and angiotensin-receptor blocker after stenting as a useful strategy for prevention of coronary restenosis. Nishikawa H; Miura S; Shimomura H; Tsujita K; Okamura K; Zhang B; Iwata A; Shirai K; Matsuo K; Arai H; Saku K J Cardiol; 2005 Mar; 45(3):107-13. PubMed ID: 15801275 [TBL] [Abstract][Full Text] [Related]
23. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis. Bauters C; Amouyel P Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837 [TBL] [Abstract][Full Text] [Related]
24. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results. Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF; Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559 [TBL] [Abstract][Full Text] [Related]
25. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade. Feng TC; Ying WY; Hua RJ; Ji YY; de Gasparo M J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of ribonucleotide reductase reduces neointimal formation following balloon injury. Henry JC; Bonar MM; Kearns PN; Cui H; Mutchler MM; Martin MV; Orsini AR; Elford HL; Bush CA; Zweier JL; Cardounel AJ J Pharmacol Exp Ther; 2005 Jul; 314(1):70-6. PubMed ID: 15814568 [TBL] [Abstract][Full Text] [Related]
27. [Neointima hyperplasia and alteration of angiotensin II AT1 receptors after coronary stent implantation]. Li G; Lin SG; Chen JY Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):96-8, 108. PubMed ID: 15684010 [TBL] [Abstract][Full Text] [Related]
28. Avβ3 single-stranded DNA aptamer attenuates vascular restenosis via Ras-PI3K/MAPK pathway in rats after percutaneous transluminal coronary angioplasty. Wu HB; Wang ZW; Shi F; Ren ZL; Li LC; Hu XP; Hu R; Li BW Artif Organs; 2020 Jun; 44(6):611-619. PubMed ID: 31879964 [TBL] [Abstract][Full Text] [Related]
29. Drug-eluting stent: the emerging technique for the prevention of restenosis. Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626 [TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty. Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720 [TBL] [Abstract][Full Text] [Related]
32. Lentivirus-mediated RNAi knockdown of the gap junction protein, Cx43, attenuates the development of vascular restenosis following balloon injury. Han XJ; Chen M; Hong T; Zhu LY; He D; Feng JG; Jiang LP Int J Mol Med; 2015 Apr; 35(4):885-92. PubMed ID: 25625334 [TBL] [Abstract][Full Text] [Related]
33. [Vascular remodeling and angiotensin II]. Takemoto M; Egashira K Nihon Rinsho; 1999 May; 57(5):1158-63. PubMed ID: 10361450 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of restenosis after coronary intervention: difference between plain old balloon angioplasty and stenting. Nakatani M; Takeyama Y; Shibata M; Yorozuya M; Suzuki H; Koba S; Katagiri T Cardiovasc Pathol; 2003; 12(1):40-8. PubMed ID: 12598017 [TBL] [Abstract][Full Text] [Related]
35. Effects of candesartan and probucol on restenosis after coronary stenting: results of insight of stent intimal hyperplasia inhibition by new angiotensin II receptor antagonist (ISHIN) trial. Wakeyama T; Ogawa H; Iida H; Takaki A; Iwami T; Mochizuki M; Tanaka T Circ J; 2003 Jun; 67(6):519-24. PubMed ID: 12808270 [TBL] [Abstract][Full Text] [Related]
36. Decoy oligodeoxynucleotide against activator protein-1 reduces neointimal proliferation after coronary angioplasty in hypercholesterolemic minipigs. Buchwald AB; Wagner AH; Webel C; Hecker M J Am Coll Cardiol; 2002 Feb; 39(4):732-8. PubMed ID: 11849876 [TBL] [Abstract][Full Text] [Related]
37. Angiotensin II type 1 receptor blockers suppress neointimal hyperplasia after stent implantation in carotid arteries of hypercholesterolemic rabbits. Ichikawa N; Toma N; Kawakita F; Matsushima S; Imanaka-Yoshida K; Yoshida T; Taki W; Suzuki HI Neurol Res; 2015 Feb; 37(2):147-52. PubMed ID: 25089806 [TBL] [Abstract][Full Text] [Related]
38. Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model. Wilson DP; Saward L; Zahradka P; Cheung PK Cardiovasc Res; 1999 Jun; 42(3):761-72. PubMed ID: 10533617 [TBL] [Abstract][Full Text] [Related]
39. Local delivery of 17-beta-estradiol decreases neointimal hyperplasia after coronary angioplasty in a porcine model. Chandrasekar B; Tanguay JF J Am Coll Cardiol; 2000 Nov; 36(6):1972-8. PubMed ID: 11092673 [TBL] [Abstract][Full Text] [Related]
40. [Neointimal hyperplasia by luminal cell recruitment and not be transmural migration. The role of Bcl-2 and HSP47 after balloon angioplasty]. Jabs A; Krämer S; Skowasch D; Welsch U; Kuhn A; Kandolf R; Lüderitz B; Bauriedel G Z Kardiol; 2002 Aug; 91(8):626-36. PubMed ID: 12426826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]